Benitec Biopharma Inc. (BNTC)

Benitec Biopharma Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	184.76	97.74	50.87	2.48	4.06	19.77
Cash & Short-Term Investments	184.76	97.74	50.87	2.48	4.06	19.77
Cash Growth	78.37%	92.16%	1953.53%	-39.02%	-79.45%	101.70%
Accounts Receivable	0	0.03	0.23	0.06	0	0.03
Other Current Assets	1.25	0.74	0.58	1.2	0.76	0.81
Total Current Assets	186.02	98.52	51.67	3.73	4.82	20.61
Net Property, Plant & Equipment	0.92	0.99	0.45	0.61	0.99	0.58
Other Long-Term Assets	0.07	0.08	0.09	0.12	0.16	0.19
Total Assets	187	99.59	52.21	4.46	5.97	21.38
Accounts Payable	2.25	1.02	4.17	3.23	1.88	0.88
Accrued Expenses	0.54	0.43	0.48	0.47	0.4	0.28
Current Portion of Leases	0.48	0.35	0.28	0.28	0.25	0.21
Total Current Liabilities	3.27	1.8	4.92	3.98	2.53	1.37
Long-Term Leases	0.39	0.5	-	0.28	0.56	-
Other Long-Term Liabilities	-	-	0.04	-	-	-
Total Long-Term Liabilities	0.39	0.5	0.04	0.28	0.56	-
Total Liabilities	3.67	2.3	4.96	4.26	3.09	1.37
Common Stock	0	0	0	-	-	0
Additional Paid-in Capital	445.19	326.31	238.4	168.92	152.45	151.58
Accumulated Other Comprehensive Income	-0.95	-0.84	-0.89	-0.83	-1.25	-1.46
Retained Earnings	-260.91	-228.18	-190.26	-167.89	-148.33	-130.12
Shareholders' Equity	183.33	97.3	47.25	0.2	2.88	20.01
Total Liabilities & Equity	187	99.59	52.21	4.46	5.97	21.38
Total Debt	0.88	0.85	0.28	0.56	0.81	0.21
Net Cash (Debt)	183.89	96.9	50.58	1.92	3.25	19.56
Net Cash Growth	89.78%	91.56%	2537.23%	-41.00%	-83.38%	108.13%
Net Cash Per Share	4.13	2.68	2.75	1.38	6.76	77.40
Book Value	183.33	97.3	47.25	0.2	2.88	20.01
Book Value Per Share	4.12	2.69	2.57	0.15	6.00	79.19
Tangible Book Value	183.33	97.3	47.25	0.2	2.88	20.01
Tangible Book Value Per Share	4.12	2.69	2.57	0.15	6.00	79.19

Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q